Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III

Biochemical Journal

Volumn 366, Issue 2, 2002, Pages 435-446

  Pimenta, Daniel C ^a   Nantes, Iseli L ^a   De Souza, Eduardo S ^a   Le Bonniec, Bernard ^a   Ito, Amando S ^a   Tersariol, Ivarne L S ^a   Oliveira, Vitor ^a   Juliano, Maria A ^a   Juliano, Luiz ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Binding assay; Glycosaminoglycan; Kallikrein; Time resolved fluorescence

Indexed keywords

CARBOXYLIC ACIDS; POLYSACCHARIDES; PROTEINS;

PEPTIDES;

BIOCHEMISTRY;

4 AMINOBENZOIC ACID; ANTITHROMBIN III; ETHYLENEDIAMINE DERIVATIVE; HEPARIN; KALLISTATIN; N (2,4 DINITROPHENYL)ETHYLENEDIAMINE; PEPTIDE DERIVATIVE; PROTAMINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; FLUORESCENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTITHROMBIN III; CARRIER PROTEINS; CIRCULAR DICHROISM; CONSENSUS SEQUENCE; FLUORESCENT DYES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; KALLIKREINS; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; SERPINS; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0036712598     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020023     Document Type: Article

References (43)

1. Glycosaminolycans: Molecular properties, protein interactions, and role in physiological processes
2. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
3. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement
4. Mobile reactive centre of serpins and the control of thrombosis
5. The anticoagulant activation of antithrombin by heparin
6. The effect of a reducing-end extension on pentasaccharide binding by antithrombin
7. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive centre loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin
8. Identification of a major heparin-binding site in kallistatin
9. Cysteine proteinase activity regulation. A possible role of heparin and heparin-like glycosaminoglycans
10. Cathepsin B activity regulation. Heparin-like glycosaminoglycans protect human cathepsin B from alkaline pH-induced inactivation
11. Identification of cell-binding sites on the Laminin α5 N-terminal domain by site-directed mutagenesis
12. Cell binding sequences in mouse laminin α1 chain
13. Defining the interleukin-8-binding domain of heparan sulfate
14. Proteoglycans: Structures and interactions
15. Heparan sulfate proteoglycans on the cell surface: Versatile coordinators of cellular functions
16. Heparan sulphate proteoglycans on the cell surface: Versatile coordinators of cellular functions
17. Design and synthesis of a helix heparin-binding peptide
18. Binding of a de novo designed peptide to specific glycosaminoglycans
19. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects
20. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and non-specific binding models
21. Design of peptides with high affinities for heparin and endothelial cell proteoglycans
22. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin
23. Interaction of heparin with synthetic antithrombin III peptide analogues
24. Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans
25. Intramolecularly quenched fluorogenic tetrapeptide substrates for tissue and plasma kallikreins
26. Fluorimetric Assays of Proteolytic Enzymes
27. Fluorogenic substrates for proteases based on intramolecular fluorescence energy transfer (IFETS)
28. End-to-end distance distribution in bradykinin observed by Förster resonance energy transfer
29. Molecular modeling of protein-glycosaminoglycan interactions
30. Heparin protects cathepsin G against inhibition by protein proteinase inhibitors
31. Internally quenched fluorogenic protease substrates: Solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyl/dinitrophenyl groups as donor-acceptor pairs
32. Behavior and analysis of rapid equilibrium and steady-state enzyme systems
33. Ion effects on ligand-nucleic acid interactions
34. Large differences in the helix propensities of alanine and glycine
35. A self-consistent method for the analysis of protein secondary structure from circular dichroism
36. A constrained regularization method for inverting data represented by linear algebraic or integral-equations
37. Identification of the antithrombin III heparin binding site
38. Fluorescent properties of amino acids labeled with ortho-aminobenzoic acid
39. Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding
40. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein
41. The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies
42. Extension and structural variability of the antithrombin-binding sequence in heparin